Nurix Therapeutics, Inc. Quarterly Operating Lease, Liability, Current in USD from Q4 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Nurix Therapeutics, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q4 2020 to Q1 2025.
  • Nurix Therapeutics, Inc. Operating Lease, Liability, Current for the quarter ending February 28, 2025 was $6.64M, a 9.18% decline year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 $6.64M -$671K -9.18% Feb 28, 2025 10-Q 2025-04-08
Q4 2024 $8.01M +$525K +7.01% Nov 30, 2024 10-Q 2025-04-08
Q3 2024 $6.55M +$1.19M +22.2% Aug 31, 2024 10-Q 2024-10-11
Q2 2024 $7.93M +$2.35M +42.1% May 31, 2024 10-Q 2024-07-11
Q1 2024 $7.31M +$1.75M +31.6% Feb 29, 2024 10-Q 2024-04-10
Q4 2023 $7.49M +$1.96M +35.4% Nov 30, 2023 10-K 2025-01-28
Q3 2023 $5.36M -$134K -2.44% Aug 31, 2023 10-Q 2023-10-12
Q2 2023 $5.58M +$113K +2.07% May 31, 2023 10-Q 2023-07-13
Q1 2023 $5.56M +$126K +2.32% Feb 28, 2023 10-Q 2023-04-13
Q4 2022 $5.53M +$1.68M +43.7% Nov 30, 2022 10-K 2024-02-15
Q3 2022 $5.5M Aug 31, 2022 10-Q 2022-10-06
Q2 2022 $5.47M May 31, 2022 10-Q 2022-07-07
Q1 2022 $5.43M Feb 28, 2022 10-Q 2022-04-08
Q4 2021 $3.85M +$505K +15.1% Nov 30, 2021 10-K 2023-02-09
Q4 2020 $3.34M Dec 1, 2020 10-Q 2022-10-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.